Its high receptor selectivity makes it a preferred reference compound for cleanly isolating GH-pathway effects without interference from cortisol or prolactin elevation
It is a meaningful step for the beneficiaries it reaches, but it is a pilot, not a promise of permanence, and beneficiaries are being urged to confirm the details of their own plans directly
Further, an increase in left atrial myocardial capillary density (1.6-fold) and phosphorylation of eNOS (twofold) was also noted
FDA-APPROVED INDICATIONS Type 2 diabetes As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus Limitations of use: has not been studied in patients with a history of pancreatitis TYPE 2 DIABETES RCT SURPASS-2 trial - Tirzepatide vs Semaglutide in Patients with Type 2 Diabetes, NEJM (2021) [PubMed abstract] The SURPASS-2 trial enrolled 1879 adults with type 2 diabetes who were inadequately controlled with metformin at a dose of at least 1500 mg per day Main inclusion criteria Age 18 years T2DM uncontrolled with metformin at 1500 mg/day A1C of 7 - 10.5% BMI 25 and stable for 3 months Main exclusion criteria Type 1 diabetes GFR 50 ng/L
That is a more structured arrangement than programs that issue a prescription and step back
In randomized, placebo-controlled trials , tirzepatide has shown promising results